A detailed history of Quest Partners LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 387 shares of YMAB stock, worth $6,072. This represents 0.0% of its overall portfolio holdings.

Number of Shares
387
Previous 1 38600.0%
Holding current value
$6,072
Previous $12,000 42308.33%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$9.95 - $15.39 $3,840 - $5,940
386 Added 38600.0%
387 $5.09 Million
Q2 2024

Aug 06, 2024

BUY
$11.6 - $17.25 $11 - $17
1 New
1 $12,000

Others Institutions Holding YMAB

About Y-mAbs Therapeutics, Inc.


  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $686M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.